EYENOVIA, INC. Files 8-K on Shareholder Vote Matters
Ticker: HYPD · Form: 8-K · Filed: Jan 24, 2025 · CIK: 1682639
| Field | Detail |
|---|---|
| Company | Eyenovia, INC. (HYPD) |
| Form Type | 8-K |
| Filed Date | Jan 24, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
TL;DR
EYENOVIA filed an 8-K for a shareholder vote - details TBD.
AI Summary
On January 21, 2025, EYENOVIA, INC. filed an 8-K report detailing a submission of matters to a vote of its security holders. The filing does not disclose specific details of the vote or the matters presented, but it indicates a formal process involving shareholder decisions is underway.
Why It Matters
This filing signals that EYENOVIA, INC. is engaging in a formal process requiring shareholder approval for significant corporate actions, which could impact the company's future direction and shareholder rights.
Risk Assessment
Risk Level: medium — The filing indicates a shareholder vote is occurring, which can introduce uncertainty regarding corporate decisions and potential changes in strategy or governance.
Key Players & Entities
- EYENOVIA, INC. (company) — Registrant
FAQ
What specific matters were submitted for a vote of EYENOVIA, INC.'s security holders?
The filing does not specify the exact matters submitted for a vote, only that a submission of matters to a vote of security holders occurred on or before January 21, 2025.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was January 21, 2025.
What is EYENOVIA, INC.'s principal executive office address?
EYENOVIA, INC.'s principal executive offices are located at 295 Madison Avenue, Suite 2400, New York, NY 10017.
What is EYENOVIA, INC.'s telephone number?
EYENOVIA, INC.'s telephone number is (833) 393-6684.
Under which section of the Securities Exchange Act of 1934 is this Form 8-K filed?
This Form 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 650 words · 3 min read · ~2 pages · Grade level 12 · Accepted 2025-01-24 16:02:05
Key Financial Figures
- $0.0001 — h registered) Common stock, par value $0.0001 per share EYEN The Nasdaq Stock Mar
Filing Documents
- tm254246d1_8k.htm (8-K) — 33KB
- 0001104659-25-005978.txt ( ) — 203KB
- eyen-20250121.xsd (EX-101.SCH) — 3KB
- eyen-20250121_lab.xml (EX-101.LAB) — 33KB
- eyen-20250121_pre.xml (EX-101.PRE) — 22KB
- tm254246d1_8k_htm.xml (XML) — 4KB
07
Item 5.07. Submission of Matters to a Vote of Security Holders. A Special Meeting of Stockholders (the "Special Meeting") of Eyenovia, Inc. ("Eyenovia" or the "Company") was held in a virtual format on January 21, 2025 starting at 10:00 AM EDT. Of Eyenovia's 111,425,129 shares of common stock, $0.0001 par value per share (the "common stock"), issued and eligible to vote as of the record date of December 9, 2024, a quorum of 58,272,257 shares, or approximately 52.3% of the eligible shares, was present virtually or represented by proxy at the Special Meeting. The actions set forth below were taken at the Special Meeting. Each of the matters set forth below is described in detail in Eyenovia's definitive proxy 1. Approval of an amendment to Eyenovia's Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the Company's issued and outstanding shares of common stock, at a ratio of between 1:40 and 1:80 (the "Reverse Stock Split Amendment"). Shares Voted For Shares Voted Against Shares Abstaining Broker Non-Votes 45,289,590 12,572,704 409,963 0 2. Approval of an amendment to Eyenovia's Amended and Restated 2018 Omnibus Stock Incentive Plan to reserve an additional 350,000 shares of the Company's common stock for issuance thereunder, which number will not be adjusted as a result of the Reverse Stock Split Amendment. Shares Voted For Shares Voted Against Shares Abstaining Broker Non-Votes 22,969,009 8,945,460 527,690 25,830,098 3. Approval of, for purposes of Nasdaq Listing Rule 5635(d), the potential issuance of up to an aggregate of 73,029,273 shares of common stock upon the exercise of the Purchase Warrants issued by the Company pursuant to the Purchase Agreements (each, as defined in the Proxy Shares Voted For Shares Voted Against Shares Abstaining Broker Non-votes 23
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EYENOVIA, INC. Date: January 24, 2025 /s/ Michael Rowe Michael Rowe Chief Executive Officer